Lassa fever encephalopathy: clinical and laboratory findings

J Trop Med Hyg. 1992 Jun;95(3):197-201.

Abstract

Clinical and laboratory findings are reported in nine patients who developed acute encephalopathy during the course of Lassa fever. The encephalopathy manifested 3-17 days after disease onset with confusion, followed rapidly by tremor (seven patients), grand mal convulsions (seven), abnormal posturing (three) and coma (eight); focal neurological signs and evidence of raised intracranial pressure were not seen. Eight patients died, most commonly from respiratory arrest following a protracted fit. Development of encephalopathy did not correlate with the presence of virus in cerebrospinal fluid (CSF), nor with virus antibodies in CSF and/or serum; thus, neither direct cytopathic nor immune-mediated mechanisms seem to be involved in its pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Aspartate Aminotransferases / blood
  • Brain Diseases / blood
  • Brain Diseases / immunology
  • Brain Diseases / metabolism
  • Brain Diseases / physiopathology*
  • Cerebrospinal Fluid / immunology
  • Cerebrospinal Fluid / microbiology
  • Female
  • Humans
  • Lassa Fever / immunology
  • Lassa Fever / metabolism
  • Lassa Fever / microbiology
  • Lassa Fever / physiopathology*
  • Lassa virus / immunology
  • Lassa virus / isolation & purification*
  • Male
  • Middle Aged
  • Seizures / etiology
  • Viremia / microbiology

Substances

  • Antibodies, Viral
  • Aspartate Aminotransferases